These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29679482)

  • 21. Precipitation as an Enabling Technology for the Intensification of Biopharmaceutical Manufacture.
    Martinez M; Spitali M; Norrant EL; Bracewell DG
    Trends Biotechnol; 2019 Mar; 37(3):237-241. PubMed ID: 30316558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput micro-scale cultivations and chromatography modeling: Powerful tools for integrated process development.
    Baumann P; Hahn T; Hubbuch J
    Biotechnol Bioeng; 2015 Oct; 112(10):2123-33. PubMed ID: 25988478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High throughput screening of particle conditioning operations: I. System design and method development.
    Noyes A; Huffman B; Godavarti R; Titchener-Hooker N; Coffman J; Sunasara K; Mukhopadhyay T
    Biotechnol Bioeng; 2015 Aug; 112(8):1554-67. PubMed ID: 25728932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromatographic purification of recombinant human erythropoietin.
    Adamíková J; Antošová M; Polakovič M
    Biotechnol Lett; 2019 May; 41(4-5):483-493. PubMed ID: 30810853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
    Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
    PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of a fermentation process for the production of two PfAMA1-DiCo-based malaria vaccine candidates in Pichia pastoris.
    Kastilan R; Boes A; Spiegel H; Voepel N; Chudobová I; Hellwig S; Buyel JF; Reimann A; Fischer R
    Sci Rep; 2017 Sep; 7(1):11991. PubMed ID: 28931852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris.
    Jiang Y; Li F; Zha D; Potgieter TI; Mitchell T; Moore R; Cukan M; Houston-Cummings NR; Nylen A; Drummond JE; McKelvey TW; d'Anjou M; Stadheim TA; Sethuraman N; Li H
    Protein Expr Purif; 2011 Mar; 76(1):7-14. PubMed ID: 21074617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in industrial biopharmaceutical batch process monitoring: Machine-learning methods for small data problems.
    Tulsyan A; Garvin C; Ündey C
    Biotechnol Bioeng; 2018 Aug; 115(8):1915-1924. PubMed ID: 29624632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cell-free expression and purification process for rapid production of protein biologics.
    Sullivan CJ; Pendleton ED; Sasmor HH; Hicks WL; Farnum JB; Muto M; Amendt EM; Schoborg JA; Martin RW; Clark LG; Anderson MJ; Choudhury A; Fior R; Lo YH; Griffey RH; Chappell SA; Jewett MC; Mauro VP; Dresios J
    Biotechnol J; 2016 Feb; 11(2):238-48. PubMed ID: 26427345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using high throughput screening to define virus clearance by chromatography resins.
    Connell-Crowley L; Larimore EA; Gillespie R
    Biotechnol Bioeng; 2013 Jul; 110(7):1984-94. PubMed ID: 23436296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caprylic acid precipitation method for impurity reduction: an alternative to conventional chromatography for monoclonal antibody purification.
    Brodsky Y; Zhang C; Yigzaw Y; Vedantham G
    Biotechnol Bioeng; 2012 Oct; 109(10):2589-98. PubMed ID: 22549395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach for the removal of protein impurities from purified biologicals using combinatorial solid-phase ligand libraries.
    Fortis F; Guerrier L; Righetti PG; Antonioli P; Boschetti E
    Electrophoresis; 2006 Aug; 27(15):3018-27. PubMed ID: 16807935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel aqueous two phase assisted platform for efficient removal of process related impurities associated with E. coli based biotherapeutic protein products.
    Bhambure R; Sharma R; Gupta D; Rathore AS
    J Chromatogr A; 2013 Sep; 1307():49-57. PubMed ID: 23921264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal Chromatography for Purification of Biotherapeutics - A Review.
    Halan V; Maity S; Bhambure R; Rathore AS
    Curr Protein Pept Sci; 2019; 20(1):4-13. PubMed ID: 29065828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caprylic acid-induced impurity precipitation from protein A capture column elution pool to enable a two-chromatography-step process for monoclonal antibody purification.
    Zheng J; Wang L; Twarowska B; Laino S; Sparks C; Smith T; Russell R; Wang M
    Biotechnol Prog; 2015; 31(6):1515-25. PubMed ID: 26280674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of tobramycin impurities for quality control process monitoring using high-performance anion-exchange chromatography with integrated pulsed amperometric detection.
    Hanko VP; Rohrer JS; Liu HH; Zheng C; Zhang S; Liu X; Tang X
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):828-33. PubMed ID: 18486398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: application of quality by design (QbD) principles.
    Jiang C; Flansburg L; Ghose S; Jorjorian P; Shukla AA
    Biotechnol Bioeng; 2010 Dec; 107(6):985-97. PubMed ID: 20683852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of protein selectivity in multimodal chromatography using in silico designed Fab fragment variants.
    Karkov HS; Krogh BO; Woo J; Parimal S; Ahmadian H; Cramer SM
    Biotechnol Bioeng; 2015 Nov; 112(11):2305-15. PubMed ID: 25950863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.